ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Daphnetin contributes to allergen-induced Th2 cytokine expression and type 2-immune responses in atopic dermatitis and asthma

Zhang, Yi; Qu, Lu; Sun, Yun; Lin, YuPing; Zeng, Jing; He, LiXia; Li, Xiucun; Gu, Wen; Nie, Jian; Yu, Xiaoling; Tong, XiaoYun*; Huang, Feng*山东大学; 云南大学; 1
Food & Function2022-11-28DOI: 10.1039/d2fo02518c
3被引27阅读
引用收藏
分享

摘要

Daphne koreana Nakai is a cherished medicinal plant in the Changbai Mountain region of China. It can be incorporated into medicinal meals and used for various skin diseases by infiltrating liquor. Daphnetin (7,8-dihydroxycoumarin, Dap.) is a main constituent of D. koreana Nakai, which has been used to treat inflammatory conditions and immune disorders due to its numerous pharmacological activities, including anti-oxidant, anti-inflammatory, analgesic, etc. Atopic dermatitis (AD) and allergic asthma are typical diseases of type 2-immune responses. In the present study, the therapeutic potential of Dap. against AD and allergic asthma was investigated using animal and cell experiments. AD-like lesions were induced by repeated application of 1-chloro-2,4-dinitrobenzene (DNCB) to the shaved dorsal skin of BALB/c mice. Ovalbumin (OVA) induction was utilized to establish a mouse asthma model. A passive cutaneous anaphylaxis (PCA) mouse ear model and immunoglobulin E (IgE)/bovine serum albumin (BSA)-stimulated RBL-2H3 cells were used for in vitro assays. The skin lesions and serum and tissue homogenates of the mice were analyzed using histological analysis, immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA), respectively, in order to investigate the anti-AD effects of Dap. Histological analysis was performed on the allergic asthma model to observe inflammatory cell infiltration in the lung tissues. Total IgE and OVA-specific IgE in the serum were measured by ELISA. The levels of inflammatory cytokines in BALF were detected by ELISA. In addition, ELISA and western blotting were performed for the in vitro analysis of RBL-2H3 cells. The results showed that Dap. inhibited the development of DNCB-induced AD-like lesions in the BALB/c mice by reducing the severity of the lesions, epidermal thickness and mast cell infiltration; this was accompanied by reduced levels of IgE and inflammatory cytokines [interleukin (IL)-4, IL-5, IL-9, IL-13, IL-33 and thymic stromal lymphopoietin (TSLP)]. In the allergic asthma model, Dap. reduced the number of infiltrated inflammatory cells in the lung tissues. Moreover, the levels of total serum IgE and OVA-specific IgE were reduced in the high daphnetin dose groups (Dap., -100 mg kg(-1)). Dap. administered at a dose of -100 mg kg(-1) decreased the levels of inflammatory cytokines (IL-4, IL-5, IL-9, IL-13, IL-33 and TSLP in BALF). Furthermore, Dap. administered to IgE-sensitized mice effectively attenuated the IgE-triggered PCA reaction. In vitro, Dap. decreased the expression levels of histamine, IL-4, IL-6, IL-13, MIP-1 alpha and INF-alpha, and reduced the protein expression levels of phosphorylated MAPKs, P-Lyn and P-syk in the RBL-2H3 cells. Therefore, Dap. can be represented as a potential therapeutic strategy for the treatment of allergic inflammatory conditions via immunoregulation.

学科与关键词

关键词
PASSIVE CUTANEOUS ANAPHYLAXISMAST-CELLSANTIALLERGIC ACTIVITYIN-VITROACTIVATIONINHIBITIONIL-1IGEINFLAMMATIONDERIVATIVES
相关
加载中…
  • Vasicine alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis and passive cutaneous anaphylaxis in BALB/c mice
    Zhang, Yi; Du, Wenxia; Zhu, Defen; Li, Meiling; Qu, Lu; Rao, Gaoxiong; Lin, Yuping; Tong, Xiaoyun; Sun, Yun*; Huang, Feng*Clinical Immunology, 2022, 244: 109102.被引 1
  • Inhibitory effects of catalpol on DNCB-induced atopic dermatitis and IgE-mediated mast cells reaction
    Sun, Yun; Zhu, Defen; Qu, Lu; Li, Manping; Du, Wenxia; Wang, Mingming; Zhang, Yi; Chen, Guifang; Rao, Gaoxiong; Yu, Xiaoling; Wu, Xiangnong; Huang, Feng*; Tong, Xiaoyun*International Immunopharmacology, 2024, 126: 111274.被引 1
  • Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis
    Yang, Mengru; Zhao, Mantong; Xia, Tianyi; Chen, Ying; Li, Wei; Zhang, Han; Peng, Mingming; Li, Chuanqiu; Cao, Xia; Liang, Lanyuan; Yue, Yimin; Zhong, Luyang; Du, Jieyong; Li, Jianhua; Wang, Yi; Shu, ZunpengBiomedicine and Pharmacotherapy, 2023, 162: 114622.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2022-11-28
卷期
第 13 卷, 第 23 期
页码
12383-12399
DOI
10.1039/d2fo02518c
语言
ENGLISH
成果收录
SCIE
资助标注
211 Project and Key Laboratory of Innovative Research Projects of College of Pharmacy of Jinan University; National Research Foundation of National Natural Science Foundation of China [81960784, 81760741, 81760775, 81860760, 82060751]; Yunnan Provincial Science and Technology Department - Applied Basic Research Joint Special Funds of Chinese Medicine [202001AZ070001-039]; Key Project of Yunnan Provincial Science and Technology Department [2019FA035, 202001AU070102]; Yunnan Innovation Team of Application Research on TCM Theory of Prevention Disease at Yunnan University of TCM [2017HC011]; Department of Science and Technology of Yunnan Province [202001AU070102, 2018FF001(-050), 2019FF002(-010)]

作者

  • Z

    Zhang, Yi (第一作者)

    yunnan univ tradit chinese med

  • Q

    Qu, Lu

    yunnan univ tradit chinese med

查看全部 12 位作者收起作者
  • S

    Sun, Yun

    yunnan univ tradit chinese med

  • L

    Lin, YuPing

    yunnan univ tradit chinese med

  • Z

    Zeng, Jing

  • H

    He, LiXia

    2 · wannan med coll

  • L

    Li, Xiucun

    shandong univ

  • G

    Gu, Wen

    yunnan univ tradit chinese med

  • N

    Nie, Jian

    yunnan univ tradit chinese med

  • Y

    Yu, Xiaoling

    yunnan univ

  • T

    Tong, XiaoYun (通讯)

    1 · yunnan univ

  • H

    Huang, Feng (通讯)

    yunnan univ tradit chinese med · yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417